[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Bioinformatics Market - Forecasts from 2018 to 2023

August 2018 | 96 pages | ID: BE36960F6BDEN
Knowledge Sourcing Intelligence LLP

US$ 3,800.00

E-mail Delivery (PDF), Hard Copy Mail Delivery, CD-ROM Mail Delivery

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The bioinformatics market is expected to grow at a CAGR of 18.15% to reach a market size of US$21.229 billion in 2023, increasing from US$7.805 billion in 2017. Bioinformatics is the application of information technology to the study of living things, usually at the molecular level. It involves the use of computers to collect, organize and use biological information to answer questions in fields like evolutionary biology. With biomedical research becoming data-intensive, bioinformatics is gaining traction. The market is expected to grow at a steady pace owing to the rising adoption of Artificial Intelligence (AI) in bioinformatics in research and healthcare sector.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the bioinformatics value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the bioinformatics market.
Key five industry participants profiled as part of this section are Ayasdi, Inc., SciGenom Labs Pvt. Ltd, TeselaGen, Hybrigenics, Agilent Technologies, and DNAnexus among others.

Segmentation

The bioinformatics market has been segmented as follows:
  • By type of Biological data:
    • DNA
    • RNA
    • Protein
    • Gene Expression Profiles
    • Chromosomal Mapping
    • Others
  • By application:
    • Drug Discovery
    • Personal and Preventive Medicine
    • Crop Improvement and Insect Resistance
    • Others
  • By geography:
    • North America
      • United States
      • Canada
      • Others
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • United Kingdom
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa (MEA)
      • UAE
      • Saudi Arabia
      • Israel
      • Others
    • Asia Pacific (APAC)
      • China
      • Japan
      • India
      • Australia
      • Others
1. INTRODUCTION

1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. RESEARCH METHODOLOGY

2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. KEY FINDINGS OF THE STUDY

4. MARKET DYNAMICS

4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
  4.5.1. Bargaining Power of Suppliers
  4.5.2. Bargaining Power of Buyers
  4.5.3. Threat of New Entrants
  4.5.4. Threat of Substitutes
  4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis – Regional Snapshot
4.7. Market Attractiveness

5. BIOINFORMATICS MARKET FORECAST BY THE TYPE OF BIOLOGICAL DATA (US$ BILLION)

5.1. DNA
5.2. RNA
5.3. Protein
5.4. Gene Expression Profile
5.5. Chromosomal Mapping
5.5. Others

6. BIOINFORMATICS MARKET FORECAST BY APPLICATION (US$ BILLION)

6.1. Drug Discovery
6.2. Personal and Preventive Medicine
6.3. Crop Improvement and Insect Resistance
6.4. Others

7. BIOINFORMATICS MARKET FORECAST BY GEOGRAPHY (US$ BILLION)

7.1. North America
  7.1.1. US
  7.1.2. Canada
  7.1.3. Others
7.2. South America
  7.2.1. Brazil
  7.2.2. Argentina
  7.2.3. Others
7.3. Europe
  7.3.1. UK
  7.3.2. Germany
  7.3.3. France
  7.3.4. Italy
  7.3.5. Spain
  7.3.6. Others
7.4 Middle East and Africa
  7.4.1. UAE
  7.4.2. Israel
  7.4.3. Saudi Arabia
  7.4.4. Others
7.5. Asia Pacific
  7.5.1. China
  7.5.2. India
  7.5.3. Japan
  7.5.4. Others

8. COMPETITIVE INTELLIGENCE

8.1. Market Share Analysis
8.2. Strategies of Key Players
8.3. Recent Investments and Deals

9. COMPANY PROFILES

9.1. Ayasdi, Inc.
  9.1.1. Overview
  9.1.2. Financials
  9.1.3. Product and Services
  9.1.4. Key Developments
9.2. SciGenome Labs Pvt. Ltd
  9.2.1. Overview
  9.2.2. Financials
  9.2.3. Product and Services
  9.2.4. Key Developments
9.3. TeselaGen
  9.3.1. Overview
  9.3.2. Financials
  9.3.3. Product and Services
  9.3.4. Key Developments
9.4. Hybrigenics
  9.4.1. Overview
  9.4.2. Financials
  9.4.3. Product and Services
  9.4.4. Key Developments
9.5. Era7 Information Technologies
  9.5.1. Overview
  9.5.2. Financials
  9.5.3. Product and Services
  9.5.4. Key Developments
9.6. Lumenogix
  9.6.1. Overview
  9.6.2. Financials
  9.6.3. Product and Services
  9.6.4. Key Development
9.7. Agilent Technologies
  9.7.1. Overview
  9.7.2. Financials
  9.7.3. Product and Services
  9.7.4. Key Development
9.8. Thermo Fisher Scientific
  9.8.1. Overview
  9.8.2. Financials
  9.8.3. Product and Services
  9.8.4. Key Development
9.9. DNAnexus
  9.9.1. Overview
  9.9.2. Financials
  9.9.3. Product and Services
  9.9.4. Key Development
List of Tables
List of Figures


More Publications